Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Navigation support not costeffective for CRC screening

Navigation support not costeffective for CRC screening PharmacoEconomics & Outcomes News 792, p20 - 2 Dec 2017 Navigation support not cost effective for CRC screening Patient navigation support by social workers does not appear to be cost effective for increasing adherence to colorectal cancer (CRC) screening in France, according to findings of a study published in Value in Health. In the cluster randomised PRADO study conducted in in northern France between April 2011 and April 2013, 16 250 patients were randomised to the navigation programme for CRC screening, with support by social workers, or to usual screening. The cost effectiveness of the navigation programme was assessed from a payer perspective (French state or French social security system) over the two-year period. Costs of usual screening were not included; direct nonmedical costs of the navigation programme were categorised as navigation costs (for equipment and services) or personnel costs (for navigators and secretarial staff) . The navigation programme significantly increased the overall screening participation rate (24.4% vs 21.1%; p=0.003), but the increase in screening rate was greater in patients with higher socioeconomic status (+4.1%; p=0.01) than in those with low socioeconomic status (+2.6%; p=0.07). The estimated incremental cost-effectiveness ratio for navigation compared with usual screening was €1212 per http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics & Outcomes News Springer Journals

Navigation support not costeffective for CRC screening

PharmacoEconomics & Outcomes News , Volume 792 (1) – Dec 2, 2017
Download PDF
1 page

Navigation support not costeffective for CRC screening

Abstract

PharmacoEconomics & Outcomes News 792, p20 - 2 Dec 2017 Navigation support not cost effective for CRC screening Patient navigation support by social workers does not appear to be cost effective for increasing adherence to colorectal cancer (CRC) screening in France, according to findings of a study published in Value in Health. In the cluster randomised PRADO study conducted in in northern France between April 2011 and April 2013, 16 250 patients were randomised to the navigation...
Loading next page...
 
/lp/springer_journal/navigation-support-not-costeffective-for-crc-screening-GkNdBwnCeS

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
ISSN
1173-5503
eISSN
1179-2043
DOI
10.1007/s40274-017-4543-1
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics & Outcomes News 792, p20 - 2 Dec 2017 Navigation support not cost effective for CRC screening Patient navigation support by social workers does not appear to be cost effective for increasing adherence to colorectal cancer (CRC) screening in France, according to findings of a study published in Value in Health. In the cluster randomised PRADO study conducted in in northern France between April 2011 and April 2013, 16 250 patients were randomised to the navigation programme for CRC screening, with support by social workers, or to usual screening. The cost effectiveness of the navigation programme was assessed from a payer perspective (French state or French social security system) over the two-year period. Costs of usual screening were not included; direct nonmedical costs of the navigation programme were categorised as navigation costs (for equipment and services) or personnel costs (for navigators and secretarial staff) . The navigation programme significantly increased the overall screening participation rate (24.4% vs 21.1%; p=0.003), but the increase in screening rate was greater in patients with higher socioeconomic status (+4.1%; p=0.01) than in those with low socioeconomic status (+2.6%; p=0.07). The estimated incremental cost-effectiveness ratio for navigation compared with usual screening was €1212 per

Journal

PharmacoEconomics & Outcomes News – Springer Journals

Published: Dec 2, 2017

There are no references for this article.